ArticleCureus2024
Bombay Blood Group: A Report of Two Cases.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Timely detection of rare blood groups can be lifesaving, as individuals with these groups can only receive blood products from donors within the same group. The Bombay blood group is characterized by the absence of A, B, and H antigens on the surface of RBCs and can be easily missed in routine blood grouping if only forward grouping is performed. In reverse grouping, it is necessary to test the patient's serum with pooled O cells to differentiate between the O and Bombay blood groups. Further workup is conducted by testing the patient's red cells with anti-H lectin (antisera), where the absence of an agglutination reaction suggests the Bombay phenotype. In blood group O testing, the patient's blood serum mixed with pooled O cells yields no agglutination reaction in reverse typing, whereas testing RBCs with anti-H lectin results in a strong agglutination reaction, as H-antigen is present at its highest concentration in these individuals. Correct diagnosis of such rare blood types can save patients' lives as well as prevent the consequences of a wrong blood transfusion. Here we present two cases that were diagnosed as having the Bombay phenotype on blood group testing in our blood bank. Both were initially misdiagnosed as blood group O by an outside laboratory. Correct diagnosis of rare blood groups in blood banks is imperative, as a misdiagnosis can result in fatal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.